Henning Urlaub
Professor
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
About
Professor Henning Urlaub is a faculty member at the Max Planck Institute for Multidisciplinary Sciences in Germany. His research specializes in the quantitative analysis of the cardiac phosphoproteome, particularly in response to acute β-adrenergic receptor stimulation in vivo. Professor Urlaub's work contributes significantly to the understanding of cardiac physiology and molecular mechanisms underlying heart function.
Articles (32)
Production of the eukaryotic ribosomal subunits (40S and 60S) is a highly dynamic process in which numerous assembly factors (AFs) coordinate structural rearrangements of pre-ribosomal complexes to achieve their mature, functional architectures. Across the domains of life, GTPases leverage their functions as molecular switches to induce conformational changes that drive key steps in subunit maturation. Three GTPases, GTPBP4, GNL2, and GNL3, have been detected in nucleolar/nucleoplasmic human pre-60S complexes. Here, we compositionally analyze the pre-ribosomal particles associated with each of these GTPases and demonstrate the requirement of these enzymes, and their abilities to bind and hydrolyze GTP, for distinct steps in pre-ribosomal RNA processing. We further reveal that the GNL3 paralog, GNL3L, also associates with pre-ribosomes, and we map GNL3L binding sites on pre-rRNAs as well as identifying RNA contact sites on GNL3L. Lack of GNL3L impairs synthesis of the 60S rRNAs and expression of GTPase-inactive GNL3L causes defects in early steps of pre-rRNA processing. Impaired GTP hydrolysis by GNL3L leads to its accumulation on pre-60S particles, together with other AFs with proximal binding sites. Our data further demonstrate that the GTPase activity of GNL3L is required for maintaining 60S subunit levels, protein synthesis, and cellular proliferation.
Year:
2026
In eukaryotes, mRNA localization is a widespread mechanism of spatial gene regulation. Amongst the best-studied examples is the directional transport of ASH1 mRNA during mitosis of the budding yeast Saccharomyces cerevisiae . ASH1 mRNA is co-transcriptionally bound by the two RNA-binding proteins She2p and Loc1p and subsequently exported. In the cytoplasm, the adapter She3p binds to She2p forming an active transport complex with the myosin motor Myo4p to mediate actin-dependent transport into the daughter cell. Loc1p stays in the nucleus where it has a second function in ribosome biogenesis. In this study, we map the interaction surface of Loc1p on She2p and observe that it does not interfere with the RNA-binding interface of She2p. Analogous to a previous report on Loc1p and RNA, we could show that also Loc1p and She2p undergo liquid-liquid phase separation (LLPS). This event is caused by electrostatic interactions and can be regulated by the phosphorylation-driven alteration of She2p’s oligomeric state. Furthermore, we observed that LLPS formation only requires the PUN motifs of Loc1p and that a ternary Loc1p-RNA-She2p complex also undergoes LLPS. In summary, our findings indicate that Loc1p co-transcriptionally recruits the nuclear ASH1 mRNA-She2p complex to LLPS, while the cytoplasmic Loc1p-lacking She2p-She3p-RNA transport complex does not form such LLPS.
Year:
2026
Metazoan histone mRNAs are a unique class of mRNAs that lack the poly(A) tail present in all other eukaryotic transcripts. Instead, they end in a conserved stem-loop (SL) structure, necessitating a decay mechanism that is distinct from deadenylation-initiated degradation. Here, combining structural and functional approaches, we elucidate molecular mechanisms of initiation of histone mRNA decay. At the end of S-phase, the RNA helicase UPF1, the exoribonuclease 3’hExo and stem-loop binding protein SLBP all contribute to histone mRNA degradation, although how they are mechanistically coupled remained unknown. The cryoEM structure of an UPF1:SL RNA complex, presented here, shows that binding of UPF1 partially melts the RNA stem in the absence of ATP, harnessing the free energy derived from RNA-binding to unwind RNA. This melting event primes the SL-RNA for decay by 3’hExo. Using biochemical and cellular analyses, we demonstrate that SLBP directly engages the UPF1 helicase core to attenuate its unwinding activity and prevent premature degradation. Activation of UPF1 at a later stage promotes SL-RNA decay. We provide direct evidence that UPF1, SLBP and 3’hExo form a degradosome-like assembly that functionally couples SL unwinding and degradation, highlighting a dynamic and intricate network of UPF1-centric interactions that orchestrates timely histone mRNA decay.
Year:
2026
Fluorescent probes enable precise visualization of dynamic cellular processes, especially when combined with super-resolution imaging techniques that overcome the diffraction limit. However, traditional labeling strategies, including fluorescent protein fusions (e.g., GFP) or ligand-linked fluorophores, often perturb protein function or induce biological side effects. Here, we report a covalent fluorescent probe for endogenous tubulin, a key cytoskeletal protein governing cell division, motility, and intracellular transport. Using cabazitaxel as a tubulin targeting moiety and silicon-rhodamine as a cell permeable fluorophore, we designed and optimized probe, 6-SiR- o -C 9 -CTX , containing a biocompatible cleavable linker with a sulfonium center. It exhibits cell permeability, fluorogenic behavior, and efficient covalent labeling of tubulin across multiple human cell lines. Importantly, taxane targeting moiety can be removed post-labeling, preserving tubulin’s functions. This labeling strategy is compatible with STED nanoscopy in both live and fixed cells, enabling high-resolution, minimally invasive cytoskeletal imaging, and advancing the toolkit for studying dynamic cellular processes.
Year:
2025
Table S1. Brunello library sgRNA normalized read counts of IRF4 sorted CRISPR screens. Table S2. Segregation score of IRF4 sorted CRISPR screens. Table S3. Glycoproteomics in STT3A or STT3B KO cells. Table S4. Brunello sgRNA Library Normalized Read Counts of CRISPR screens. Table S5. CRISPR screen score of essentiality screens. Table S6. Glycoproteomics after NGI-1 treatment. Table S7.HBL1 and TMD8 Phosphotyrosone Phosphoproteome (pYome). Table S8. TMD8 CD79A-BioID. Table S9. HBL1 CD22 BioID. Table S10. Brunello library sgRNA normalized read counts of NGI-1 drug modified screen (TMD8). Table S11. CRISPR screen score of NGI-1 drug modifier screen. Table S12. TMD8 Drug screen Excess HSA.
Year:
2025
Supplemental Figure 1. IRF4-GFP knock-in reporter cell lines. Supplemental Figure 2. IRF4-GFP CRISPR screen in adult T-cell lymphoma and screen controls. Supplemental Figure 3. The OST is essential for DLBCL. Supplemental Figure 4. The role of the OST complex in radiation chimeras. Supplemental Figure 5. The B-cell receptor is glycosylated by the OST complex. Supplemental Figure 6. B-cell receptor deglycosylation leads to higher surface expression. Supplemental Figure 7. B-cell receptor deglycosylation leads to signaling changes in proximal BCR signaling components. Supplemental Figure 8. BCR deglycosylation leads to recruitment of CD22 on the cell surface to the BCR and signaling alterations in GCB DLBCL. Supplemental Figure 9. BCR internalization and My-T-BCR formation in glycosylation deficient cells. Supplemental Figure 10. NGI-1 synergizes with BTK and PI3K inhibitors.
Year:
2025
H3K36me3 is a hallmark of actively and recently transcribed genes and contributes to cellular memory and identity. The deposition of H3K36me3 occurs co-transcriptionally when the methyltransferase SETD2 associates with RNA polymerase II. Here we present three cryo-EM structures of SETD2 bound to RNA polymerase II elongation complexes at different states of nucleosome passage. Together with functional probing, our results suggest a 3-step mechanism of transcription-coupled H3K36me3 deposition. First, binding to the elongation factor SPT6 tethers the catalytic SET domain in proximity to the upstream DNA. Second, RNA polymerase II nucleosome passage leads to the transfer of a hexasome from downstream to upstream, poised for methylation. Finally, continued transcription leads to upstream nucleosome reassembly, partial dissociation of the histone chaperone FACT and sequential methylation of both H3 tails, completing H3K36me3 deposition of an upstream nucleosome after RNA polymerase II passage.
Year:
2025
The protein IWS1 (Interacts with SPT6 1) is implicated in transcription-associated processes, but a direct role in RNA polymerase (Pol) II function is unknown. Here, we use multi-omics kinetic analysis after rapid depletion of IWS1 in human cells to show that loss of IWS1 results in a global decrease of RNA synthesis and a global reduction in Pol II elongation velocity. We then resolve the cryo-EM structure of the activated Pol II elongation complex with bound IWS1 and elongation factor ELOF1 and show that IWS1 acts as a scaffold and positions downstream DNA within the cleft of Pol II. In vitro assays show that the disordered C-terminal region of IWS1 that contacts the cleft of Pol II is responsible for stimulation of Pol II activity and is aided by ELOF1. Finally, we find that the defect in transcription upon IWS1 depletion leads to a decrease of histone H3 tri-methylation at residue lysine-36 (H3K36me3), but that this secondary effect is an indirect function of IWS1. In summary, our structure-function analysis establishes IWS1 as a Pol II-associated elongation factor that acts globally to stimulate Pol II elongation velocity and ensure proper co-transcriptional histone methylation.
Year:
2025
Antibiotic resistance is a growing threat, underscoring the need to understand the underlying mechanisms. Aminoglycosides kill bacteria by disrupting translation fidelity, leading to the synthesis of aberrant proteins. Surprisingly, mutations in fusA , a gene encoding translation elongation factor G (EF-G), frequently confer resistance, even though EF-G neither participates in mRNA decoding nor blocks aminoglycoside binding. Here, we show that EF-G resistance variants selectively slow ribosome movement along mRNA when aminoglycosides are bound. This delay increases the chance that the drug dissociates before misreading occurs. Over several elongation cycles, this selective silencing of drug-bound ribosomes prevents error cluster formation, preserving proteome and membrane integrity. As a result, fusA mutations confer resistance early in treatment by preventing self-promoted aminoglycoside uptake. Translation on drug-free ribosomes remains sufficiently rapid to sustain near-normal bacterial growth. This previously unrecognized resistance mechanism— selective silencing of corrupted targets—reveals a novel antibiotic resistance strategy with potential therapeutic implications.
Year:
2025
Fluorescent probes enable the visualization of dynamic cellular processes with high precision, particularly when coupled with super-resolution imaging techniques that surpass the diffraction limit. Traditional methods include fluorescent protein fusion (e.g., GFP) or organic fluorophores linked to ligands targeting the protein of interest. However, these approaches often introduce functional disruptions or ligand-associated biological effects. Herein, we address these challenges by developing covalent fluorescent probes for endogenous tubulin, a critical cytoskeletal protein involved in processes such as cell movement, division, and biomolecule trafficking. Using well-known tubulin binder cabazitaxel and cell permeable fluorophore silicon-rhodamine as a basis, we introduce a novel biocompatible cleavable linker containing a sulfonium center. This allowed the construction of the optimized probe, 6-SiR- o -C 9 -CTX , demonstrating excellent cell permeability, fluorogenic properties, and the ability to covalently label tubulin across various human cell lines. Importantly, the targeting moiety could be washed out while preserving tubulin staining, ensuring minimal disruption of tubulin function. This labeling technique is compatible with STED nanoscopy in both live and fixed cells, offering a powerful high-resolution imaging tool.
Year:
2025
Year:
2025
Year:
2025
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2021
Collaborators (37)
William Marzluff
Professor
University of North Carolina at Chapel Hill
Sergei Moshkovskii
Max Planck Institute for Multidisciplinary Sciences
Dina Grohmann
University of Regensburg
Jiji Chen
National Institutes of Health
Thorsten Allers
Professor of Archaeal Genetics
University of Nottingham
Hauke Hillen
Assistant Professor
University Medical Center Göttingen
Grazvydas Lukinavicius
Resear group leader
Max Planck Institute for Multidisciplinary Sciences
Yansheng Liu
Associate Professor (Secondary)
Yale University School of Medicine
Niels Fischer
Project Group Leader
Max Planck Institute for Multidisciplinary Sciences
Oliver Kohlbacher
Professor
University of Tübingen
Robert Reichelt
University of Regensburg
Yanlong Ji
Research Lab Specialist Senior
University of Michigan
Clive DSantos
Head of Proteomics
University of Cambridge
Daniel James Hodson
-
Jae Woo Choi
Yonsei University Health System
Thomas Monecke
Staff Scientist
Ulm University
Christof Lenz
Director Core Facility Proteomics
University Medical Center Göttingen
George Wright
National Institutes of Health
Anita Marchfelder
Prof. Dr
Universität Ulm
Seychelle Vos
Assistant Professor
Massachusetts Institute of Technology
Pedro Beltrao
Associate Professor
ETH Zürich
Sutapa Chakrabarti
Associate Professor
Freie Universität Berlin
Katherine E. Bohnsack
Group leader
University Medical Center Göttingen
Thomas Oellerich
Goethe University Frankfurt
Dierk Niessing
Professor & Head of Institute
Ulm University
Silvio O Rizzoli
University Medical Center Göttingen
Christoph Engel
Prof. for Structural Biochemistry (Tenure Track)
University of Regensburg
Kristina Žumer
Project Group Leader
Max Planck Institute for Multidisciplinary Sciences
Ingo Wohlgemuth
Project Group Leader
Max Planck Institute for Multidisciplinary Sciences
Antonio Politi
Staff Scientist
Max Planck Institute for Multidisciplinary Sciences
Bernhard Loll
Principial Investigator
Freie Universität Berlin
Ricarda Richter-Dennerlein
Professor
University Medical Center Göttingen
Uri Gophna
Tel Aviv University
Susanne Erdmann
Professor for Microbiology
University of Innsbruck
Janosch Hennig
Full Professor
University of Bayreuth
James Phelan
National Cancer Institute
Eugenio F Fornasiero
Independent Group Leader
University Medical Center Göttingen
Make your next move.
Prepare your application
Review drafts before you send them.